Elekta AB (publ)
OTC: EKTAY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Jakob Just-Bomholt
- Employees
- 4,541
- Headquarters
- Stockholm, Sweden
- IPO year
- 2009
- Market cap
- $1.8B
- Website
- https://www.elekta.com
Loading EKTAY…
Loading profile data…Frequently asked questions about EKTAY
What does Elekta AB (publ) (EKTAY) do?
Elekta AB (publ) is a global medical technology company dedicated to developing and delivering advanced clinical solutions for the treatment of cancer and brain disorders. Its comprehensive portfolio includes innovative radiotherapy systems such as the Elekta Unity MR-Linac, the Elekta Harmony linear accelerator, Elekta Infinity for diverse pati...
Where does EKTAY trade?
Elekta AB (publ) (EKTAY) trades on the Other OTC.
What sector is EKTAY in?
Elekta AB (publ) (EKTAY) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Elekta AB (publ)?
Jakob Just-Bomholt is the chief executive officer of Elekta AB (publ) (EKTAY).
Where is Elekta AB (publ) headquartered?
Elekta AB (publ) is headquartered in Sweden.
Does EKTAY pay a dividend?
Yes — Elekta AB (publ) (EKTAY) paid a trailing twelve-month dividend of USD 0.26 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did EKTAY go public?
Elekta AB (publ) (EKTAY) completed its initial public offering in 2009.
Is EKTAY an ADR?
Yes — EKTAY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Elekta AB (publ) reporting and dividends follow the underlying issuer.